These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 12773967)
1. New monoclonal antibodies in renal transplantation. Vincenti F Minerva Urol Nefrol; 2003 Mar; 55(1):57-66. PubMed ID: 12773967 [TBL] [Abstract][Full Text] [Related]
2. New immunosuppressive therapies in renal transplantation: monoclonal antibodies. Buhaescu I; Segall L; Goldsmith D; Covic A J Nephrol; 2005; 18(5):529-36. PubMed ID: 16299678 [TBL] [Abstract][Full Text] [Related]
3. Induction immunotherapy with IL-2Ra monoclonal antibody in kidney transplantation. Ahsan N Minerva Urol Nefrol; 2003 Mar; 55(1):67-79. PubMed ID: 12773968 [TBL] [Abstract][Full Text] [Related]
4. Evolving trends in induction therapy. Arias M; Campistol JM; Vincenti F Transplant Rev (Orlando); 2009 Apr; 23(2):94-102. PubMed ID: 19298940 [TBL] [Abstract][Full Text] [Related]
5. Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status. Swiatecka-Urban A Paediatr Drugs; 2003; 5(10):699-716. PubMed ID: 14510627 [TBL] [Abstract][Full Text] [Related]
6. Maintenance immunosuppression with intermittent intravenous IL-2 receptor antibody therapy in renal transplant recipients. Gabardi S; Catella J; Martin ST; Perrone R; Chandraker A; Magee CC; McDevitt-Potter LM Ann Pharmacother; 2011 Sep; 45(9):e48. PubMed ID: 21811001 [TBL] [Abstract][Full Text] [Related]
7. Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys. Hausen B; Klupp J; Christians U; Higgins JP; Baumgartner RE; Hook LE; Friedrich S; Celnicker A; Morris RE Transplantation; 2001 Sep; 72(6):1128-37. PubMed ID: 11579312 [TBL] [Abstract][Full Text] [Related]
8. Role of anti-interleukin-2 receptor antibodies in kidney transplantation. Cibrik DM; Kaplan B; Meier-Kriesche HU BioDrugs; 2001; 15(10):655-66. PubMed ID: 11604047 [TBL] [Abstract][Full Text] [Related]
9. Novel immunosuppression: small molecules and biologics. Yabu JM; Vincenti F Semin Nephrol; 2007 Jul; 27(4):479-86. PubMed ID: 17616278 [TBL] [Abstract][Full Text] [Related]
10. A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. Vincenti F; Mendez R; Pescovitz M; Rajagopalan PR; Wilkinson AH; Butt K; Laskow D; Slakey DP; Lorber MI; Garg JP; Garovoy M Am J Transplant; 2007 Jul; 7(7):1770-7. PubMed ID: 17564637 [TBL] [Abstract][Full Text] [Related]
11. Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys. Bîrsan T; Hausen B; Higgins JP; Hubble RW; Klupp J; Stalder M; Celniker A; Friedrich S; O'Hara RM; Morris RE Transplantation; 2003 Jun; 75(12):2106-13. PubMed ID: 12829920 [TBL] [Abstract][Full Text] [Related]
12. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960 [TBL] [Abstract][Full Text] [Related]
13. Comparison of basiliximab and daclizumab with triple immunosuppression in renal transplantation. Aktas S; Colak T; Baskin E; Sevmis S; Ozdemir H; Moray G; Karakayali H; Haberal M Transplant Proc; 2011 Mar; 43(2):453-7. PubMed ID: 21440732 [TBL] [Abstract][Full Text] [Related]
14. Chronic induction. What's new in the pipeline. Vincenti F Contrib Nephrol; 2005; 146():22-29. PubMed ID: 15567917 [TBL] [Abstract][Full Text] [Related]
15. Monocyte-mediated acute renal rejection after combined treatment with preoperative Campath-1H (alemtuzumab) and postoperative immunosuppression. Zhang PL; Malek SK; Prichard JW; Lin F; Yahya TM; Schwartzman MS; Latsha RP; Skaletsky M; Norfolk ER; Brown RE; Hartle JE; Potdar S Ann Clin Lab Sci; 2004; 34(2):209-13. PubMed ID: 15228236 [TBL] [Abstract][Full Text] [Related]